Morphine/lidocaine topical spray - EpiCept
Alternative Names: EpiCept™MP/DP; EpiCept™MS Spray; Lidocaine/morphine; LidoPAINMP/DP; MS SprayLatest Information Update: 17 Aug 2007
At a glance
- Originator Memorial Sloan-Kettering Cancer Center
- Developer EpiCept Corporation
- Class
- Mechanism of Action Opioid receptor agonists; Sodium channel antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Pain
Most Recent Events
- 30 Jun 2004 Phase-II clinical trials in Pain in USA (Topical)
- 31 Aug 2000 Phase-I clinical trials in Pain in USA (Topical)